These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7990448)

  • 1. Drugs-of-abuse testing in urine: statistical approach and experimental comparison of immunochemical and chromatographic techniques.
    Ferrara SD; Tedeschi L; Frison G; Brusini G; Castagna F; Bernardelli B; Soregaroli D
    J Anal Toxicol; 1994 Sep; 18(5):278-91. PubMed ID: 7990448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multiple-site laboratory evaluation of three on-site urinalysis drug-testing devices.
    Crouch DJ; Frank JF; Farrell LJ; Karsch HM; Klaunig JE
    J Anal Toxicol; 1998 Oct; 22(6):493-502. PubMed ID: 9788525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization and validation of CEDIA drugs of abuse immunoassay tests in serum on Hitachi 912.
    Kirschbaum KM; Musshoff F; Schmithausen R; Stockhausen S; Madea B
    Forensic Sci Int; 2011 Oct; 212(1-3):252-5. PubMed ID: 21775079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of immunochemical drug screenings of whole blood samples. A retrospective optimization of cutoff levels after confirmation-analysis on GC-MS and HPLC-DAD.
    Kroener L; Musshoff F; Madea B
    J Anal Toxicol; 2003; 27(4):205-12. PubMed ID: 12820742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of ONTRAK TESTCUP, abuscreen ONTRAK, abuscreen ONLINE, and GC/MS urinalysis test results.
    Crouch DJ; Cheever ML; Andrenyak DM; Kuntz DJ; Loughmiller DL
    J Forensic Sci; 1998 Jan; 43(1):35-40. PubMed ID: 9456522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of Abusign drugs-of-abuse slide tests with particluar emphasis on concentrations near the cutoff: comparison with FPIA-ADx and confirmation of results with GC-MS.
    Ros JJ; Pelders MG; Egberts AC
    J Anal Toxicol; 1998; 22(1):40-4. PubMed ID: 9491967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS.
    Boettcher M; Haenseler E; Hoke C; Nichols J; Raab D; Domke I
    Clin Lab; 2000; 46(1-2):49-52. PubMed ID: 10745981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug screening in urine by cloned enzyme donor immunoassay (CEDIA) and kinetic interaction of microparticles in solution (KIMS): a comparative study.
    Schwettmann L; Külpmann WR; Vidal C
    Clin Chem Lab Med; 2006; 44(4):479-87. PubMed ID: 16599844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference of common household chemicals in immunoassay methods for drugs of abuse.
    Warner A
    Clin Chem; 1989 Apr; 35(4):648-51. PubMed ID: 2539273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the triage system for emergency drugs-of-abuse testing in urine.
    Wu AH; Wong SS; Johnson KG; Callies J; Shu DX; Dunn WE; Wong SH
    J Anal Toxicol; 1993; 17(4):241-5. PubMed ID: 8371556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a human on-site urine multidrug test for emergency use with dogs.
    Teitler JB
    J Am Anim Hosp Assoc; 2009; 45(2):59-66. PubMed ID: 19258416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The determination of drugs of abuse in whole blood by means of FPIA and EMIT-dau immunoassays--a comparative study.
    Bogusz M; Aderjan R; Schmitt G; Nadler E; Neureither B
    Forensic Sci Int; 1990 Nov; 48(1):27-37. PubMed ID: 2279719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of the novel immunoassay TRIAGE to a rapid detection of antemortem drug abuse.
    Röhrich J; Schmidt K; Bratzke H
    J Anal Toxicol; 1994; 18(7):407-14. PubMed ID: 7861755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of cloned enzyme donor immunoassay cut-offs for drugs of abuse in whole blood of drivers involved in road accidents.
    Pelletti G; Garagnani M; Rossi F; Roffi R; Barone R; Pelotti S
    Forensic Sci Int; 2019 Jan; 294():27-33. PubMed ID: 30447484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of urinary benzodiazepines and their metabolites: comparison of automated HPLC and GC-MS after immunoassay screening of clinical specimens.
    Valentine JL; Middleton R; Sparks C
    J Anal Toxicol; 1996 Oct; 20(6):416-24. PubMed ID: 8889678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ONTRAK TESTCUP: a novel, on-site, multi-analyte screen for the detection of abused drugs.
    Towt J; Tsai SC; Hernandez MR; Klimov AD; Kravec CV; Rouse SL; Subuhi HS; Twarowska B; Salamone SJ
    J Anal Toxicol; 1995 Oct; 19(6):504-10. PubMed ID: 8926746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External quality assessment of techniques for the detection of drugs of abuse in urine.
    Wilson JF; Smith BL; Toseland PA; Williams J; Burnett D; Hirst AD; Watson ID; Horn AN
    Ann Clin Biochem; 1994 Jul; 31 ( Pt 4)():335-42. PubMed ID: 7979098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Confirmation of Syva enzyme multiple immunoassay technique (EMIT) d.a.u. and Roche Abuscreen radioimmunoassay (RIA) (125I) urine cannabinoid immunoassays by gas chromatographic/mass spectrometric (GC/MS) and bonded-phase adsorption/thin-layer chromatographic (BPA-TLC) methods.
    Kogan MJ; Al Razi J; Pierson DJ; Willson NJ
    J Forensic Sci; 1986 Apr; 31(2):494-500. PubMed ID: 3011956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First analytical chemistry study on drug abuse in the Buenos Aires (Argentina) University students.
    Quiroga PN; Panzuto RI; Alvarez GB; Mirson DJ; Ochoa CF; Assem EM; López CM; Schkolnik LC; Villaamil EC; Roses OE
    Farmaco; 1998 Jun; 53(6):389-94. PubMed ID: 9764470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of screening immunoassays to detect sub-threshold concentrations of cocaine, cannabinoids, and opiates in urine: use for detecting maternal and neonatal drug exposures.
    Hattab EM; Goldberger BA; Johannsen LM; Kindland PW; Ticino F; Chronister CW; Bertholf RL
    Ann Clin Lab Sci; 2000 Jan; 30(1):85-91. PubMed ID: 10678589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.